298 related articles for article (PubMed ID: 31620140)
1. Heterogeneity of HBV-Specific CD8
Heim K; Neumann-Haefelin C; Thimme R; Hofmann M
Front Immunol; 2019; 10():2240. PubMed ID: 31620140
[TBL] [Abstract][Full Text] [Related]
2. T-cell therapy for chronic viral hepatitis.
Bertoletti A; Tan AT; Koh S
Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
[TBL] [Abstract][Full Text] [Related]
3. A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.
Moshkani S; Chiale C; Lang SM; Rose JK; Robek MD
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541859
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy and therapeutic vaccines for chronic HBV infection.
Lang-Meli J; Neumann-Haefelin C; Thimme R
Curr Opin Virol; 2021 Dec; 51():149-157. PubMed ID: 34710645
[TBL] [Abstract][Full Text] [Related]
5. Immunological cure of HBV infection.
Lang J; Neumann-Haefelin C; Thimme R
Hepatol Int; 2019 Mar; 13(2):113-124. PubMed ID: 30600480
[TBL] [Abstract][Full Text] [Related]
6. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8
Murata Y; Kawashima K; Sheikh K; Tanaka Y; Isogawa M
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089700
[TBL] [Abstract][Full Text] [Related]
8. The CD8+ T cell exhaustion mechanisms in chronic hepatitis B infection and immunotherapeutic strategies: a systematic review.
Allahmoradi E; Mohammadi R; Kheirandish Zarandi P; Alavian SM; Heiat M
Expert Rev Clin Immunol; 2023 Jun; 19(6):671-688. PubMed ID: 37013795
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy.
Webster GJ; Reignat S; Brown D; Ogg GS; Jones L; Seneviratne SL; Williams R; Dusheiko G; Bertoletti A
J Virol; 2004 Jun; 78(11):5707-19. PubMed ID: 15140968
[TBL] [Abstract][Full Text] [Related]
10. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice.
Krebs K; Böttinger N; Huang LR; Chmielewski M; Arzberger S; Gasteiger G; Jäger C; Schmitt E; Bohne F; Aichler M; Uckert W; Abken H; Heikenwalder M; Knolle P; Protzer U
Gastroenterology; 2013 Aug; 145(2):456-65. PubMed ID: 23639914
[TBL] [Abstract][Full Text] [Related]
11. Type I Interferon Signaling Prevents Hepatitis B Virus-Specific T Cell Responses by Reducing Antigen Expression.
Kawashima K; Isogawa M; Hamada-Tsutsumi S; Baudi I; Saito S; Nakajima A; Tanaka Y
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209178
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic vaccination against chronic hepatitis B virus infection.
Michel ML; Mancini-Bourgine M
J Clin Virol; 2005 Dec; 34 Suppl 1():S108-14. PubMed ID: 16461209
[TBL] [Abstract][Full Text] [Related]
13. Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength.
de Beijer MTA; Jansen DTSL; Dou Y; van Esch WJE; Mok JY; Maas MJP; Brasser G; de Man RA; Woltman AM; Buschow SI
J Virol; 2020 Mar; 94(7):. PubMed ID: 31852786
[TBL] [Abstract][Full Text] [Related]
14. Hepatic expansion of virus-specific CD8
Wang H; Wu B; Li L; Hu L; Lin J; Jiang C; Cai G; Shen Q
Cell Immunol; 2017 Jan; 311():36-45. PubMed ID: 27743606
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of the failed immune response in chronic HBV: therapeutic implications.
Maini MK; Schurich A
J Hepatol; 2010 Apr; 52(4):616-9. PubMed ID: 20185199
[TBL] [Abstract][Full Text] [Related]
16. Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.
Khakpoor A; Ni Y; Chen A; Ho ZZ; Oei V; Yang N; Giri R; Chow JX; Tan AT; Kennedy PT; Maini M; Urban S; Bertoletti A
J Virol; 2019 Feb; 93(4):. PubMed ID: 30518652
[TBL] [Abstract][Full Text] [Related]
17. Harnessing CD8
Yue B; Gao Y; Hu Y; Zhan M; Wu Y; Lu L
Clin Transl Med; 2024 Jul; 14(7):e1731. PubMed ID: 38935536
[TBL] [Abstract][Full Text] [Related]
18. Overcoming CD8+ T-Cell Exhaustion in Viral Hepatitis: Lessons from the Mouse Model and Clinical Perspectives.
Wieland D; Hofmann M; Thimme R
Dig Dis; 2017; 35(4):334-338. PubMed ID: 28468011
[TBL] [Abstract][Full Text] [Related]
19. Targeting virus-specific CD8+ T cells for treatment of chronic viral hepatitis: from bench to bedside.
Lang-Meli J; Neumann-Haefelin C; Thimme R
Expert Opin Biol Ther; 2024; 24(1-2):77-89. PubMed ID: 38290716
[TBL] [Abstract][Full Text] [Related]
20. Discrepant Clinical Significance of CD28
Shen XH; Xu P; Yu X; Song HF; Chen H; Zhang XG; Wu MY; Wang XF
Viral Immunol; 2018 Oct; 31(8):548-558. PubMed ID: 30117787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
